Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis

被引:0
作者
Fan, Hua [1 ]
Shen, Ruile [1 ]
Yan, Junqiang [1 ]
Bai, Yongjie [1 ]
Fu, Qizhi [1 ]
Shi, Xiaofei [1 ]
Du, Ganqin [1 ]
Wang, Dongmei [1 ]
机构
[1] Henan Univ Sci & Technol, Coll Clin Med, Affiliated Hosp 1, Luoyang 471003, Peoples R China
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2024年 / 18卷
关键词
multiple sclerosis; gut microbiota; pyroptosis; gut-brain axis; neuroinflammation; therapeutic targets; CENTRAL-NERVOUS-SYSTEM; NLRP3 INFLAMMASOME ACTIVATION; BRAIN-BARRIER DISRUPTION; CHAIN FATTY-ACIDS; T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; BACTERIAL PEPTIDOGLYCAN; MONONUCLEAR-CELLS; DOUBLE-BLIND; BLOOD;
D O I
10.2147/DDDT.S489454
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review elucidates the pivotal role of pyroptosis, triggered by gut microbiota, in the development of multiple sclerosis (MS), emphasizing its significance within the gut-brain axis. Our comprehensive analysis of recent literature reveals how dysbiosis in the gut microbiota of MS patients-characterized by reduced microbial diversity and shifts in bacterial populations-profoundly impacts immune regulation and the integrity of the central nervous system (CNS). Pyroptosis, an inflammatory form of programmed cell death, significantly exacerbates MS by promoting the release of inflammatory cytokines and causing substantial damage to CNS tissues. The gut microbiota facilitates this detrimental process through metabolites such as short-chain fatty acids and neuroactive compounds, or self-structural products like lipopolysaccharides (LPS), which modulate immune responses and influence neuronal survival. This review highlights the potential of modulating gut microbiota to regulate pyroptosis, thereby suggesting that targeting this pathway could be a promising therapeutic strategy to mitigate inflammatory responses and preserve neuronal integrity in patients with MS.
引用
收藏
页码:6145 / 6164
页数:20
相关论文
共 165 条
  • [1] Exploring the Role of Neurotransmitters in Multiple Sclerosis: An Expanded Review
    Akyuz, Enes
    Celik, Betul Rana
    Aslan, Feyza Sule
    Sahin, Humeyra
    Angelopoulou, Efthalia
    [J]. ACS CHEMICAL NEUROSCIENCE, 2023, 14 (04): : 527 - 553
  • [2] Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives
    Altieri, Clelia
    Speranza, Barbara
    Corbo, Maria Rosaria
    Sinigaglia, Milena
    Bevilacqua, Antonio
    [J]. NUTRIENTS, 2023, 15 (04)
  • [3] Disruption of central nervous system barriers in multiple sclerosis
    Alvarez, Jorge Ivan
    Cayrol, Romain
    Prat, Alexandre
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (02): : 252 - 264
  • [4] Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews
    Amatya, Bhasker
    Khan, Fary
    Galea, Mary
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (01):
  • [5] Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling
    Antonopoulos, Christina
    Russo, Hana M.
    El Sanadi, Caroline
    Martin, Bradley N.
    Li, Xiaoxia
    Kaiser, William J.
    Mocarski, Edward S.
    Dubyak, George R.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (33) : 20167 - 20184
  • [6] T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
    Arbore, Giuseppina
    West, Erin E.
    Spolski, Rosanne
    Robertson, Avril A. B.
    Klos, Andreas
    Rheinheimer, Claudia
    Dutow, Pavel
    Woodruff, Trent M.
    Yu, Zu Xi
    O'Neill, Luke A.
    Coll, Rebecca C.
    Sher, Alan
    Leonard, Warren J.
    Koehl, Jorg
    Monk, Pete
    Cooper, Matthew A.
    Arno, Matthew
    Afzali, Behdad
    Lachmann, Helen J.
    Cope, Andrew P.
    Mayer-Barber, Katrin D.
    Kemper, Claudia
    [J]. SCIENCE, 2016, 352 (6292)
  • [7] Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
    Argaw, Azeb Tadesse
    Asp, Linnea
    Zhang, Jingya
    Navrazhina, Kristina
    Trinh Pham
    Mariani, John N.
    Mahase, Sean
    Dutta, Dipankar J.
    Seto, Jeremy
    Kramer, Elisabeth G.
    Ferrara, Napoleone
    Sofroniew, Michael V.
    John, Gareth R.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (07) : 2454 - 2468
  • [8] Nigericin Promotes NLRP3-Independent Bacterial Killing in Macrophages
    Armstrong, Heather
    Bording-Jorgensen, Michael
    Chan, Richard
    Wine, Eytan
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [9] The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial
    Asghari, Kimia Motlagh
    Dolatkhah, Neda
    Ayromlou, Hormoz
    Mirnasiri, Fatemeh
    Dadfar, Taher
    Hashemian, Maryam
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course
    Baranzini, Sergio E.
    iMSMS Consortium
    [J]. CELL, 2022, 185 (19) : 3467 - +